Source: International Congress 2019 – Airway diseases and blood cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kovchun (Sumy, Ukraine), V. Kmyta (Sumy, Ukraine), L. Prystupa (Sumy, Ukraine). Systemic inflammation in patients with COPD and anemia of chronic disease. 2584

Member's Comments

No comment yet.

Related content which might interest you: Systemic inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD): are anaemia of chronic disease and erythropoietin resistance the missing links? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Correction of the anemia of chronic disease among COPD patients Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Prevalence of anemia of chronic disease in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 The potential impact of anaemia of chronic disease in COPD Source: Eur Respir J 2006; 27: 390-396 Year: 2006 Systemic inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD diagnosis Year: 2013 COPD as a systemic disease Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy Year: 2007 Prevelance of anemia in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Erythropoietin in chronic obstructive pulmonary disease patients without anemia Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 The impact of anemia of chronic disease on exercise capacity among patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Clinical physiology for clinical problems Year: 2011 Inflammation in COPD: a link to systemic comorbidities Source: Eur Respir Rev 2007; 16: 91-97 Year: 2007 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Systemic effects in patients with chronic obstructive pulmonary disease: a role of disease duration and disease severity Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020